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Abstract
Many patients show no or incomplete responses to current pharmacological or psychological therapies for depression. Here
we explored the feasibility of a new brain self-regulation technique that integrates psychological and neurobiological
approaches through neurofeedback with functional magnetic resonance imaging (fMRI). In a proof-of-concept study, eight
patients with depression learned to upregulate brain areas involved in the generation of positive emotions (such as the
ventrolateral prefrontal cortex (VLPFC) and insula) during four neurofeedback sessions. Their clinical symptoms, as assessed
with the 17-item Hamilton Rating Scale for Depression (HDRS), improved significantly. A control group that underwent
a training procedure with the same cognitive strategies but without neurofeedback did not improve clinically. Randomised
blinded clinical trials are now needed to exclude possible placebo effects and to determine whether fMRI-based
neurofeedback might become a useful adjunct to current therapies for depression.
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Introduction
Depression is the mental disorder with the largest impact on
public health. Up to 20% of the population suffers from
a depressive episode at some point in their lives [1], and major
depressive disorder (MDD) is a main source of disability for adults
of working age in industrialized countries. At least 30% of patients
with MDD do not respond to standard pharmacological and/or
psychological treatments [2], and a considerable number of those
who do respond initially go on to develop a chronic relapsing-
remitting disorder. These patients with no or only a partial
response to standard treatments often enter a vicious circle of
psychosocial decline with further deterioration of their mood and
level of functioning. To prevent relapses new therapeutic strategies
have to be developed that aid the restructuring of cognitive
schemas and might even prevent the formation and crystallization
of dysfunctional thought patterns during early phases of de-
pression.
Over the last two decades, several new treatment techniques
have been developed that were at least partly motivated by
neuroimaging findings. These invasive [3] and non-invasive brain
stimulation techniques [4] target the neural circuits believed to be
involved in the maintenance of dysfunctional cognitive patterns
and to change their activity in response to treatment [5,6].
Although two new stimulation techniques (Vagus Nerve Stimula-
tion, VNS; Transcranial Magnetic Stimulation, TMS) have
received FDA approval, one of them requires a surgical procedure
(VNS) and the other (TMS) has had mixed clinical effects [4].
Moreover, even the most effective stimulation technique–electro-
convulsive therapy (ECT)–has only relatively short-lived effects
[7]. The alternative, or complementary approach of teaching
patients strategies that would eventually become self-sustainable
has traditionally been the domain of cognitive behavioral therapy
(CBT). Although CBT has recently been linked with neuroimaging
to assess its neural effects [5,6], neuroimaging findings have not
directly been integrated in the therapeutic process.
Here we report a proof of concept study for a neuroimaging-
based technique that tries to achieve such integration by
combining concepts from brain stimulation, cognitive restructur-
ing and emotion regulation research. This technique, functional
magnetic resonance imaging (fMRI)-based neurofeedback, entails
training patients to regulate their emotion circuits themselves
through neurofeedback. The continuously updated neurofeedback
signal shows the activity level in the targeted area, thereby
providing patients with online information about their success in
regulating their own brain activity.
Several studies have demonstrated that healthy participants
[8–11] and patients with schizophrenia [12] can learn self-
regulation of brain areas involved in emotion processing through
real-time feedback of local fMRI signals, and successful self-
regulation was associated with altered appraisal of aversive
stimuli [13]. The first clinical application of fMRI-based
neurofeedback in patients with chronic pain has been promising.
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cingulate cortex, an area involved in the affective processing of
pain, was associated with a reduction in pain ratings [14]. In the
present study we localized areas responsive to positively valenced
visual stimuli adapted from the International Affective Pictures
System (IAPS) [15,10] and then trained patients with unipolar
depression to upregulate the activity in this target region over
four sessions. We hypothesized that the combination of the
physiological upregulation and the reinforced training of positive
thought patterns would lead to an improvement of mood, which
would not be seen in a control group that engaged in an emotion
regulation protocol without neurofeedback.
Materials and Methods
Participants
Eight patients with a DSM-IV diagnosis of major depression
(Recurrent Depressive Disorder: 296.3) and no co-morbid DSM-
IV pathology were recruited from outpatient clinics into the
experimental (neurofeedback: NF) group. We subsequently
recruited a control group to undergo an imagery (IM) procedure
outside the scanner to control for non-specific effects of study
participation and emotional imagery. Both groups were ap-
proached by their clinicians about their interest in participating in
a research study exploring the effects of new treatments for
depression. A psychiatrist (S.L.) confirmed each patient’s diagnosis
using a clinical interview based on the Structured Interview for
DSM-IV (SCID). All participants were recruited from the same
clinics and had to adhere to identical criteria, and the two groups
did not differ in mean age (NF=48.38 years; IM: 48.5 years;
t(14)=20.18, p=.99), duration of illness (NF=19.25 years,
IM=19.15 years; t(14)=0.19, p=.99), or handedness (one left-
handed individual in each group), but there were three females in
the IM group and only males in the NF group. All patients had
been on a stable dose of antidepressant medication for at least six
weeks preceding the intervention. The groups were comparable in
terms of their drug treatment. Six NF patients were treated with
antidepressants (AD) only; one, with AD and lithium; and one,
with an AD and an antipsychotic. Seven IM patients were treated
with an AD only; and one with an AD and lithium. For additional
details, see Table 1.
Ethics Statement
The research was conducted in accordance with the Declaration
of Helsinki and all patients gave informed written consent before
taking part in the study. The study received approval from the
ethics committees of the School of Psychology, Bangor University,
and the North West Wales NHS Trust. Patients received
a monetary compensation of £10 per hour for their time and
effort. All patients were debriefed about their individual strategies
and about potential distress upon completion of the post-
intervention assessments. Because it employed an experimental
rather than clinical trial design the study was not registered in
a public trials database.
General Procedure
All patients completed an initial testing session that included the
clinical interview, an assessment of their depression with the
HDRS, their reward sensitivity (Behavioural Inhibition System
and Behavioural Activation System (BIS/BAS) [16]), and their
metacognitive dispositions (Thought Control Questionnaire
(TCQ) [17] and Thought Control Ability Questionnaire (TCAQ)
[18]). The first experimental session immediately followed. Each
session started and ended with an assessment of the patient’s
current mood using the Profile of Mood States (POMS [19]) and
the Positive Affect Negative Affect Schedule (PANAS [20]).
Immediately following the pre-intervention assessment, the
patients in the NF group underwent the fMRI-neurofeedback
procedure and the IM group performed the matched imagery.
The second, third, and fourth experimental sessions were given at
1–2 weekly intervals during a period of 4–6 weeks. Immediately
after the fourth session, the HDRS was administered again.
Description of Psychometric Tests
Measures of depression and current mood state. The
main outcome measure of clinical effects was the 17-item HDRS,
which is a clinical rating scale that captures core components of
the depressive syndrome and a standard measure of treatment
outcome. We administered the full 21-item HDRS through
a standardized interview by a board-certified psychiatrist (one of
co-authors D.L., D.H., R.T., or S.L.). The sequential group
allocation we had to implement made it impossible to blind the
psychiatrists. We also assessed effects on current mood state with
the POMS and PANAS before and after each session. On the
POMS Standard Form [20], patients circle the number that
correspond to their current mood state (0= ‘‘not at all’’, 1= ‘‘a
little’’, 2= ‘‘moderately’’, 3= ‘‘quite a bit’’, 4= ‘‘extremely’’) on
sixty-five items. The higher the score that is obtained on this test,
the greater the Total Mood Disturbance (TMD) that is experi-
enced, and a drop in TMD was expected after each neurofeedback
session. The POMS has satisfactory test-retest reliability, and
internal consistency is satisfactory [21]. The PANAS is a self-
report scale that consists of 20 items that state 10 positive and 10
negative feelings or emotions, which have to be scored on a scale
from 1 to 5 (1= ‘‘very slightly or not at all’’, 2= ‘‘a little’’, 3=
‘‘moderately’’, 4= ‘‘quite a bit’’, 5= ‘‘extremely’’). It was
expected that the scores on the positive scale would increase after
a neurofeedback session and those on the negative scale would
decrease. It has high internal consistency and high factorial,
convergent, and discriminant validity [19].
Measures of reward sensitivity and thought control. The
BIS/BAS questionnaire [16] consists of 24 statements that belong
to one of the four scales: BIS, BAS reward responsiveness, BAS
drive or BAS fun seeking. The participants scored these statements
on a scale from 1 to 4 (1= ‘‘very false for me’’, 2= ‘‘somewhat
false for me’’, 3= ‘‘somewhat true for me, 4= ‘‘very true for me’’).
This questionnaire was administered at the beginning of the
experiment to obtain an indication of control over motivational
behaviour. A high score on the BIS scale is associated with
sensitivity to signals of punishment which causes the inhibition of
goal achievement. High scores on the BAS scales on the other
hand imply sensitivity to signals of reward, which leads to
a reinforcement of goal-directed behaviour. The BIS/BAS scales
have good internal reliability and factor validity [22]. The TCQ
consists of 30 sentences which describe a certain strategy that can
be adopted when one experiences an unpleasant or unwanted
thought and measures five factors: reappraisal, distraction,
punishment, social control and worry. For each strategy patients
marked whether they ‘‘never’’, ‘‘sometimes’’, ‘‘often’’ or ‘‘almost
always’’ engaged in that particular strategy upon experiencing
intrusive thoughts. A high score on the TCQ implies that the
respondent adopts more adaptive strategies to control his or her
thoughts. It has an acceptable test-retest reliability [17]. The
TCAQ is composed of 25 statements that give an indication of
how well patients are in suppressing unwanted thoughts [18].
Patients rated these statements on a 5-point Likert scale (‘‘strongly
disagree’’, ‘‘disagree’’, ‘‘neutral or don’t know’’, ‘‘agree’’ or
‘‘strongly agree’’). A higher score on the TCAQ is associated
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TCAQ has high internal consistency and retest reliability [23]. We
obtained these measures to ensure that any group differences in
clinical outcome were not produced by baseline differences in
reward sensitivity or perceived self-control.
FMRI Procedure (NF group)
Patients in the NF group were trained to upregulate brain areas
responsive to positive emotions using a procedure modeled on our
previous work with healthy participants [10]. A target area was
identified by the contrast between responses to positive and neutral
images in a localizer scan to ensure that an area involved in
positive emotion processing was selected. In the localizer scan, we
assessed brain responses to positive, negative and neutral pictures
by presenting four pictures of the same emotion category in blocks
of 6 s (1.5 s per picture), alternating with a fixation baseline of
12 s. We presented 12 blocks per category in pseudorandom
order. We used pictures from the IAPS [15] with negative (mean
normative ratings for valence 2.8 [SD.42], arousal 5.63 [SD.55]),
positive (valence 6.90 [.55], arousal 6.00 [.74]) and neutral valence
(valence 5.45 [.56], arousal 3.44 [.47]). Pictures showed, for
example, scenes of danger or disgust in the negative category, and
scenes of romance including mild erotica or exciting sports in the
positive category. After the localizer scan, patients were trained to
upregulate the target area during three neurofeedback scans
lasting ca. 7 minutes each per session (Fig. 1). Patients were
informed about the general function of the target area but were
not given any specific instructions about strategy. The task we set
for them was to increase activity in the target area by as much and
as consistently as possible.
We acquired fMRI data on a 3 Tesla Philips Achieva magnetic
resonance imaging system (Philips Healthcare, Best, The Nether-
lands) using a single shot echo-planar imaging sequence (TR=2 s,
TE=30 ms, 27 slices, 3 mm slice thickness, inplane resolution
2m m 62 mm, soft tone mode). Patients were instructed to keep
head movement to a minimum and fixate the middle of the
picture/thermometer display during visual presentation, avoiding
eye movements.
For the neurofeedback, a continuous signal from the target area
(updated every TR and thus every 2 seconds) was displayed using
the picture of a thermometer whose dial indicated the amplitude of
the fMRI signal in the target area. Changes in the amplitude were
indicated as the percent of signal change, calculated using the
current signal intensity value and comparing it with the average
value determined from the rest period immediately preceding each
upregulation block. The scaling of the thermometer was in steps of
Table 1. Patient demographic characteristics.
No. Age Gender Handedness Duration of illness (years) Medication (daily doses)
NF group
1 54 M L 1 lofepramine 140 mg, mirtazapine 30 mg
2 67 M R 49 amitriptyline 75 mg
3 37 M R 6 tranylcypromin 40 mg, lithium 400 mg
4 21 M R 2 fluoxetine 40 mg
5 44 M R 20 mirtazapine 30 mg
6 56 M R 20 sertraline 200 mg, reboxetine 8 mg
7 47 M R 25 citalopram 60 mg, quetiapine 100 mg
8 61 M R 31 fluoxetine 20 mg
IM group
9 39 M R 20 duloxetine 60 mg
10 59 M R 9 lithium 1200 mg, venlafaxine 225 mg
11 65 F R 40 sertraline 100 mg
12 49 M R 20 reboxetine 4 mg
13 64 F R 12 citalopram 20 mg
14 29 M L 18 citalopram 30 mg
15 44 F R 20 citalopram 20 mg
16 39 M R 14 citalopram 40 mg
doi:10.1371/journal.pone.0038115.t001
Figure 1. Neurofeedback protocol. During the neurofeedback runs
(3 in each of the 4 sessions), participants alternated between 20 s
periods of rest and 20 s periods where they had to upregulate activity
in the target area. The level of activation was fed back in real time
(updated for each TR of 2 s) through the thermometer display.
doi:10.1371/journal.pone.0038115.g001
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background colour every 20 s indicated to participants whether
their task was to regulate (green background) or rest (yellow
background). The online GLM was computed with one predictor
for the regulation state, convolved with a haemodynamic reference
function. The top one-third (defined by the t value for the contrast
between the regulation predictor and baseline) of the voxels from
the target region was used to compute the feedback signal. For
runs in which participants failed to upregulate the target area
during the regulation periods (negative percent signal change),
another target area was selected for the next run, using the cluster
with the strongest activation for the regulation predictor. This
adjustment in the target area was necessary in 15/32 (47.9%) of
the sessions after the first NF run, and in 4 sessions after the second
run. The reasons for this approach were two-fold. First, the
adjustment of ROIs aided the shaping of mental strategies in the
desired direction. Shaping is a common concept in the operant
learning of a highly demanding task [11]. Secondly, our focus was
not so much on the ability of participants to learn to regulate
a specific brain region but on the effects of the NF training
procedure on participants’ mood.
Control Procedure (IM group)
The control intervention used the same basic stimulation
procedure as the NF intervention, but it was performed outside
the scanner. Patients were instructed to engage in positive imagery
strategies similar to those reported by the NF group and to evoke
positive memories during the blocks on which the background
screen was green, and to rest during the blocks on which it was
yellow.
FMRI Data Analysis
For offline analysis, we performed the customary steps in three-
dimensional fMRI analysis using the BrainVoyager QX (Brainin-
novation, Maastricht, the Netherlands) software package. The
data were preprocessed using motion correction, temporal high
pass filtering (2 sine/cosine pairs, or 0.005 Hz) and smoothing (3 s)
and spatial smoothing (6 mm), following procedures described
elsewhere [9]. For the region-of-interest (ROI) analysis, beta values
and t-statistics for the upregulation predictor were extracted for the
neurofeedback runs for each target ROI in order to obtain
a measure of the participant’s self-regulation performance. The t-
values were then entered into a 2-way repeated measures ANOVA
(run: 3 levels; session: 4 levels) with subject as random factor. We
also computed a 2-way ANOVA with the same factors on the
whole-brain data in Talairach space in order to identify the overall
network supporting the NF training task. Thresholds were
identified for the whole brain maps at p,.05 voxelwise, with
cluster correction at p=.05, using the cluster-level correction
algorithm implemented in Brainvoyager to correct for multiple
comparisons [24]. (For individual contrasts in the ANOVA, a more
stringent threshold of p,.001 was used, corrected for multiple
comparisons in the same way as the whole brain maps.).
Psychometric Data Analysis
The psychometric data were analyzed in SPSS 16.0 (SPSS Inc.,
Chicago, IL, USA) with t-tests or analysis of covariance
(ANCOVA) as appropriate. All the variates tested as being
approximately normal (Kolmogorov-Smirnoff test, all ps ..3).
Correlation Analysis
Correlations between each patient’s up-regulation improve-
ment, as defined by a subtraction of the average t-value during the
final session from the first session, and improvement on the
HDRS, POMS and PANAS subscales were computed using
Spearman’s rank correlation test.
Results
We allocated 16 patients with a diagnosis of recurrent
depression to a neurofeedback (NF, N=8) or an imagery control
(IM, N=8) group. Patient groups were matched for demographic
characteristics and clinical parameters (Table 1). The groups were
also identical in terms of the severity of depressive symptoms
before the intervention (HDRS-21 mean: NF=18.125;
IM=17.75, t(14)=0.15, p=.89; HDRS-17 mean: NF=14.375;
IM=13.88, t(14)=0.23, p=.82) and on reward sensitivity (BIS/
BAS) and metacognitive measures (TCQ, TCAQ) (all ps ..1).
Neurofeedback Success
Patients in the NF group successfully learned to upregulate the
target area, as indicated by a significant intercept in a repeated-
measures ANOVA (F [1,7]=6.88, p=034) (Fig. 2). The effect of
run was significant (F [2,14]=4.08, p=04), but neither the effect
of Session nor the Session x Run interaction was significant (ps.3).
The effect of run was produced by a linear increase from Run 1 to
Run 3 (linear contrast: F [1,7]=5.72, p=048). The Session x Run
interaction for the linear contrast was marginally significant (F
[1,7]=4.31, p=076), reflecting the steeper increase in the first two
sessions compared to Sessions 3 and 4. The target areas (which
could comprise more than one anatomical region) were in the
right (28 runs) or left (34 runs) ventrolateral prefrontal cortex
(VLPFC), the left (29 runs) or right (19 runs) insula, the left (11
runs) or right (11 runs) dorsolateral prefrontal cortex (DLPFC), the
left (2 runs) or right (1 run) medial temporal lobe or the
orbitofrontal cortex (1 run), regions strongly implicated in the
control of emotions [25]. Since it was required to adjust the target
ROI during a substantial number of runs two additional analyses
were performed. Firstly, it was investigated how up-regulation
affected the initial ROIs that were selected during run 1. The
effects of both run and session were not significant (p.3 and p.2
respectively) and the Session x Run interaction showed a trend
towards significance (F [6,42]=1.89, p=106). Secondly, we
investigated whether a learning curve was present for the first
neurofeedback run of each session and found a significant positive
linear trend (F [1,7]=7.077, p,05), indicating improved control
across sessions of the ROI that was selected based on the
functional localizer.
Clinical and Psychometric Measures
The NF group showed significant clinical improvement on the
HDRS-17 (Fig. 3). A repeated-measures ANOVA with the factors
Time (pre/post-intervention) and Group (NF/IM) yielded a signif-
icant interaction (F [1,14]=10.15, p=007). To rule out an effect
of gender imbalance across groups the same analysis was repeated
with the factor Gender included as covariate, and similar results
were obtained (F [1,13]=9.36, p=009). The HDRS-17 scores of
patients in the NF group decreased significantly (4.13 points
(SD=2.75) from a mean of 14.38 to 10.25, t(7)=4.24, p=.004),
but the change in the IM group (from 13.88 to 14.88) was not
significant, t(7)=20.78, p=46). The effect size (Cohen’s d) of the
improvement from treatment in the NF group was 1.5. Before the
intervention, all patients had scores .8, but after the intervention,
two of the NF patients had remitted (HDRS-17,8 [26]), and three
additional NF patients (and one patient in the IM group) had
scores of 8, thus fulfilling the criterion used in CBT trials for full
treatment response [27]. Whereas clinical improvement was
Neurofeedback in Depression
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improvement in current mood on the POMS. This effect was
supported by a significant intercept in a 2-way repeated-measures
ANOVA performed on the difference scores (F [1,14]=21.7,
p,001). After correcting for Gender and TMD baseline (TMD
pre-test session 4– session 1) no significant effects (ps.1) were
found apart from a significant Session x TMD baseline interaction
(F [3,36]=6.60, p=001), indicating that the size of TMD
improvement decreased over sessions and with reduced TMD
baseline scores. On PANAS NA difference scores, the NF group
was significantly lower than the IM group (F [1,14]=16.18,
p,001), indicating that the NF group decreased their NA scores
more than the IM group. However, neither the Session effect nor
the Group x Session interaction was significant (ps.7). The
inclusion of Gender and PANAS NA baseline (PANAS NA pre-
test session 4– session 1) as covariates did not alter any of these
results (Group effect (F [1,12]=17.95, p=001), Session effect
(ps.4), Group x Session interaction (ps.5)). A significant
interaction was found between Session and PANAS NA baseline
(F [3,36]=13.66, p,001). An ANOVA yielded no significant
effects for the PA scores (ps.2), and adding Gender and PANAS
PA baseline (PANAS PA pre-test session 4– session 1) as covariates
only returned a significant Session x PANAS PA baseline
interaction (F [3,36]=40.29, p,001).
The significant Session x Baseline score interactions were
further investigated. For this purpose, patients were divided into
a high improvement group (scores . median) and low improve-
ment group (scores , median) and the effect of Session was tested.
A significant Session x Improvement group interaction was found
for TMD (F [3,42]=8.20, p,001), PANAS NA (F [3,33]=5.81,
p=003) and PANAS PA (F [3,33]=7.69, p,001). These
interactions were driven by the finding that the improvement
groups that showed the most within-session improvement during
early sessions showed a significantly linear decreased within-
session improvement over session. For PANAS PA and NA this
trend was shown by the low improvement group ((F [1,6]=10.49,
p=018) and (F [1,6]=6.81, p=04) respectively), for TMD by the
high improvement group (F [1,7]=22.22, p=002).
A significant positive correlation was found between up-
regulation improvement and improvement on HDRS (r=747,
p=033). Thus, the better a patient was at up-regulating the target
area during the final session in comparison to the first, the more
points a patient improved on the HDRS. No significant
correlation was found between up-regulation improvement and
POMS (p.7) or PANAS PA (p.7) or NA (p.4).
Whole-brain fMRI Results
Group analysis of the contrast between conditions with positive
and neutral images (Table 2, Fig. 4) in the localizer scans yielded
activation in the bilateral VLPFC/insula region, which is
consistent with its prominence in the individual contrast maps
producing the target areas. Additional areas with higher activation
to positive images included the ventromedial PFC, parts of the
cingulate cortex, regions in the bilateral DLFPC and bilateral
parietal cortex, and higher visual areas.
Activation increases during upregulation periods of the
neurofeedback scans included but were not confined to the
individual target regions. Rather, the group map for the
upregulation predictor showed activation of the bilateral anterior
insula and hippocampal regions, bilateral medial premotor and
Figure 2. Neurofeedback success. Although self-regulation performance was varied during the first run (indicated by the low t values, scaled on
the y-axis), participants achieved reliable upregulation during runs 2 and 3, with more stability in the later sessions. Data points represent group
means and error bars represent the SD.
doi:10.1371/journal.pone.0038115.g002
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(Fig. 5a, Table 3). Deactivation was prominent in the bilateral
temporoparietal junction (TPJ), and it extended into the posterior
insula, early and higher visual areas, and the right DLPFC (Fig. 5a,
Table 3). Significantly higher activation in the upregulation
periods of the late (Weeks 3 and 4) compared to early (Weeks 1
and 2) sessions was observed in the bilateral ventral striatum, and
in left extrastriate visual cortex (p,001, cluster level corrected; see
Fig. 5b and Table 3).
Neurofeedback Strategies Debriefing
Patients in the NF group reported initially using imagery of the
positive scenes in the localizer scan in an attempt to increase
activation in the target brain areas, but they later changed to
evoking memories and imagery of autobiographically relevant
material. For example, the happy memories that they reported as
successful strategies included holidays, thoughts about their family
being happy, and imagery of beautiful scenes from nature. Some
patients attained good self-regulation of the target areas through
mental simulation of future successes, and one patient successfully
used imagery of an out-of-body experience. Conversely, during
rest periods, the patients reported trying to ‘‘empty their thoughts’’
and to meditate. Patients in the IM group were instructed to
engage in similar strategies as those reported by the NF patients.
At debriefing, they confirmed that they had used these strategies.
No patient reported any distress arising from the procedure.
Discussion
In the present study, four sessions of non-invasive fMRI-
neurofeedback reduced the symptoms of depression with an effect
size similar to those obtained with deep brain stimulation (DBS)
[3]. Although the mental strategies of positive thoughts, memories,
and imagery may have played a considerable part in this
improvement, the neurofeedback procedure was crucial as
evidenced by the absence of any clinical improvement in the
control group. This effect of the neurofeedback intervention can
be a result of several factors, including the self-regulation of
emotion networks, but also non-specific effects of reward
experience and scanner environment. These potential confounds
and strategies for overcoming them in future studies will be
discussed below. The lack of improvement in the control group
may seem surprising at first, considering the often reported
placebo responses in drug trials. However, enrolment in drug trials
raises very different expectations to a brief emotion regulation
intervention, and control or waiting list groups of psychotherapy
Figure 3. Neurofeedback produced clinical improvement that was not seen in the control group. Patients in the neurofeedback (NF)
treatment group, but not those in the imagery (IM) control group, improved significantly on the 17-item Hamilton Depression Rating scale, a standard
clinical measure of depression severity and treatment effects. Lower values denote clinical improvement (error bars: standard errors).
doi:10.1371/journal.pone.0038115.g003
Figure 4. The localiser procedure identified networks of
positive mood. Higher activation of right insula (INS), ventral striatum
(VS), anterior cingulate cortex (ACC) and ventromedial prefrontal cortex
(VMPFC) during presentation of positive compared to neutral images in
the localiser runs (for full list of areas see Table 2). The localiser runs
were effective in identifying brain areas responsive to positive images,
which were used as target regions of interests (ROIs) for the subsequent
neurofeedback procedure. The figure shows the contrast map
thresholded at p,.05 (cluster level corrected) on a sample brain seen
from the right and front (Talairach coordinates of virtual cuts: x=0,
y=0,z=22).
doi:10.1371/journal.pone.0038115.g004
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feasibility of the technique in patients with depression, which is
important in light of the often reported motivational deficits in this
patient group, this study thus shows encouraging clinical effects,
which need to be corroborated in clinical trials.
The significant interactions between Session on the one hand
and baseline TMD and PANAS on the other hand showed that
within-session improvements on the POMS and PANAS are
influenced by the improvement over time, which can result in
ceiling effects. However, none of these factors interacted with
Group and thus different sensitivity to the mood measures does not
seem to have influenced the key results of our study. Whereas
groups did not differ in the immediate mood effect as measured
with the POMS, a questionnaire that does not capture the full
syndrome of depression, only the NF group improved significantly
on the HDRS, which captures more sustained clinical effects, after
treatment. This suggests that the neurofeedback procedure mainly
enhanced the consolidation of the patients’ improved control over
their mood states. This interpretation would conform to a recent
report that emotion regulation without neurofeedback resulted in
immediate but not sustained effects at the neural level in patients
with major depression [29]. The finding that patients who became
better at up-regulating their target area also improved more on the
HDRS supports this finding. The non-significant correlation
Table 2. Areas activated for contrast ‘‘positive’’ vs. ‘‘neutral’’ images in the group map of the localizer procedure.
Anatomical label Talairach coordinates (x/y/z) Cluster size (mm
3)
R IPL 50/226/40 3129
RI T 43/265/26 6215
R POJ 30/276/26 4962
Bil VMPFC/VLPFC (including Bil insula) 22/36/4 26032
R DMPC 30/23/44 1048
R DLPFC 19/40/44 1500
R Caudate nucleus 14/0/15 691
ACC 3/23/26 1032
L DLPFC 216/40/40 2629
L POJ 222/280/26 1114
L DLPFC 233/9/46 2628
L Lentiform nucleus 219/26/12 852
L IPL 243/238/32 6724
L EVC 243/268/0 6792
L DLPFC 239/40/20 922
Abbreviations: R = right, L = left, Bil = bilateral, ACC = anterior cingulate gyrus; D/VLPFC = dorso/ventrolateral prefrontal cortex; D/VPMC = dorsal/ventral premotor
cortex, EVC = extrastriate visual cortex; IPL = inferior parietal lobule, POJ = parieto-occipital junction; IT = inferior temporal cortex.
doi:10.1371/journal.pone.0038115.t002
Figure 5. Network activation and deactivation during neurofeedback. a) Activation of the insular cortex (INS) bilaterally and the right ventral
striatum (VS) supported the neurofeedback task, whereas the temporoparietal junctions (TPJ) of both hemispheres were deactivated. The TPJ is
recognised as part of the brain’s ‘‘default mode network’’ that is deactivated during effortful tasks. For a full documentation of the activated and
deactivated networks see Table 3. View from the front and above. The right side of the brain is on the observer’s left (Talairach coordinates of virtual
cuts: y=25, z=22). b) Successive training sessions produced further increases of activation during upregulation periods in the VS bilaterally (coronal
view at y=7, the right side of the brain is on the observer’s left).
doi:10.1371/journal.pone.0038115.g005
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as expected as improvement on these scales leveled off after large
improvements during early sessions and was also seen in the
control group. One attractive interpretation of our results in the
context of current cognitive models of depression is that the NF
patients managed to activate positive cognitive schemas that were
otherwise dormant [5]. The interplay of cognitive and operant
strategies is also reflected in the pattern of areas that were
activated or deactivated regardless of the specific target area (Fig. 5,
Table 3). The activation of cognitive control areas in the prefrontal
cortex and of the hippocampal complex would be compatible with
the active selection of the appropriate autobiographical strategy
for positive mood induction and cognitive appraisal of emotions,
whereas activation of the ventral striatum, which increased during
the later sessions, has been associated with both operant learning
and rewarding experiences [30,31]. The deactivation of the TPJ
(equivalent to higher activation during the rest epochs) is
compatible with the role of this area in the ‘‘default mode
network’’ and its deactivation during attention-demanding pro-
cesses [32]. The focal pattern of activation and deactivations
during the upregulation blocks also makes it unlikely that the
increasing activation of the target area was achieved by some non-
specific physiological artifact. Nevertheless, to completely rule out
this possibility, online monitoring of peripheral physiological
parameters should have been conducted and future studies should
incorporate these measures. The feasibility of fMRI-neurofeed-
back under online control for potential movement [41] or
physiological changes [45] has been demonstrated. Because the
control group was not scanned we do not know whether their
execution of the imagery procedure involved similar patterns of
brain activation. However, in a study with a similar design (albeit
only one session) in healthy individuals where both groups were
scanned we found clear differences in the training effects on the
activation of the emotion network [9]. It is also worth noting that
the initial target area identified for positive affective stimuli varied
across sessions for the same participant, although it was mostly
located in ventrolateral prefrontal cortex or the insula. Without
a scanned control group we cannot say whether this reflects
a changing emotion regulation during the neurofeedback pro-
cedure [33] or whether it merely indicates normal variability in the
brain’s response to emotional stimuli over time [34]. We do not
believe that the activation patterns found for emotion regulation in
the present study primarily reflect patients’ medication because the
few studies investigating the neural correlates of emotion
regulation in unmedicated depressed patients obtained compara-
ble results. Medication-free patients have shown increased activity
in the insula and frontal regions and decreased activity in temporal
and parietal regions during an emotion reappraisal task [35,36]
and decreased DLPFC activity on an emotional information
processing task [37].
Conceptually, fMRI-based neurofeedback combines the princi-
ples of cognitive-behavioral therapy (CBT) with those of physical
Table 3. Neurofeedback-related activation and deactivation (group whole-brain analysis).
a) Areas activated during upregulation periods
Anatomical label Talairach coordinates (x/y/z) Cluster size (mm
3)
L IFG/insula 239/17/14 20960
L cuneus 217/252/9 10825
LH C 228/229/27 6548
R PHG 30/247/2 3397
R insula 25/19/16 4077
R VS 9/6/0 1294
L DMPFC 213/43/36 3708
Bil Medial frontal gyrus 25/7/48 1643
b) Areas deactivated during upregulation periods
Anatomical label Talairach coordinates (x/y/z) Cluster size (mm
3)
R TPJ 52/248/24 24077
L TPJ 254/227/20 15250
R DLPFC 39/27/33 12355
R posterior insula 33/213/6 1918
R EVC 32/289/1 3787
Bil PVC 29/272/10 35879
c) Areas with increased activity during late compared to early session
Anatomical label Talairach coordinates (x/y/z) Cluster size (mm
3)
Bil VS 211, 9, 5 13, 15, 6 1073 969
L EVC 233, 279. 27 6298
Abbreviations: See Table 2; additionally: DMPFC = dorsomedial prefrontal cortex; HC = hippocampal complex; IFG = inferior frontal gyrus; PHG = parahippocampal
gyrus; PVC = primary visual cortex; TPJ = temporo-parietal junction; VS = ventral striatum; EVC = extrastriate visual cortex.
doi:10.1371/journal.pone.0038115.t003
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techniques, it has the advantage of enhancing the patient’s self-
efficacy [38], which is an important principle in cognitive
restructuring. Neurofeedback combines biological and cognitive
treatment principles in a way that differentiates it both from
traditional biofeedback [39] and cognitive therapy and may
therefore be particularly useful for patients who have not
responded to or are reluctant to engage in psychological therapies.
The feedback element and success control could constitute an
incentive for patients who are not sufficiently motivated for
standard psychotherapies. Another attraction of the fMRI-
neurofeedback technique lies in its adaptability to individual
target areas that may differ across individuals and time. However,
in order to stabilize long-term benefits, homework assignments or
booster sessions might be usefully added to the present protocol.
The present study was a proof of concept of the feasibility of
neurofeedback and its potential clinical benefits in depression.
One limitation of the present study was the absence of blinding
and randomization, and randomized controlled trials are needed
to corroborate the clinical benefits. Lack of randomization and
sequential group allocation can induce demographic or pro-
cedural biases, which can only be partly controlled for by
including them as confounds in a covariance analysis. Yet
patients assigned to the NF or IM group were recruited via the
exact same resources and showed no meaningful differences in
demographics apart from the uneven gender distribution, which
needs to be addressed in future studies in order to assess whether
the effect generalizes to female patients. Moreover, the testing of
both groups overlapped in time period and both groups engaged
in a task that required the same mental strategies and time
commitment.
It might be useful to use Quality of Life scales and self-reported
clinical scales to capture the patients’ response to treatment
without the potential biases of unblinded assessments. However,
by their very nature, procedures with a strong cognitive
component are impossible to execute in a completely blinded
design. A potential effect of task setting, if any, would hamper the
performance of patients in the NF group who carried out the task
in a noisy and highly confined space. The clinical and functional
improvement suggests that the effects of neurofeedback can
overcome these suboptimal circumstances, thereby strengthening
the plausibility of neurofeedback for alleviating depression. It
could be argued that the exposure to a technologically advanced
method may have boosted confidence in the neurofeedback
method or otherwise created a placebo effect, thereby decreasing
the HDRS scores of the experimental group only, although there is
no reported evidence for clinical improvements from scanning
alone [40]. Yet future studies need to keep task setting more
similar between groups, especially with regard to the use of highly
technical equipment. A ‘‘sham’’ feedback procedure that presents
on average similar success signals as in the active group but is not
contingent on actual brain regulation is a possibility, but it cannot
be excluded that patients will notice the non-contingency of the
feedback. In our recent fMRI-neurofeedback study in patients
with Parkinson’s disease we did rule out non-specific effects of the
scanner environment on functional improvement [41]. All pre-
vious studies incorporating a control group did not find an effect of
sham feedback either [8,13,14,42–45]. It is certainly possible,
though, that the experience of successful self-regulation of brain
activity, quite independent of the target area, produces beneficial
clinical effects. This possibility needs to be addressed in future
studies employing different target systems in the brain. Another
neurofeedback variable that needs to be carefully considered in
future trials is block duration. The significant difference between
positive emotion up-regulation and rest suggests that a block
length of 20 s was appropriate for our study, yet future studies
might benefit from employing longer block durations in order to
give patients more time to disengage from the mental processes
utilized for upregulation.
Our study differed from most other neurofeedback studies in
that we flexibly adjusted the target area for subsequent runs based
on areas that were upregulated in the previous run. This
procedure was intended to support the shaping of learned
responses because of the limitation of scanning time and the need
to minimize patient frustration. However, this procedure may also
have made it more difficult for patients to find the optimal up-
regulation strategy and may overestimate the within session
learning effect. Another limitation is that we cannot isolate the
effective mechanism or mechanisms of the neurofeedback pro-
cedure from the present study. Although our data suggest that
neurofeedback of emotion networks is more effective than emotion
regulation without brain signals, we cannot determine the relative
contribution of the general experience of gaining control about
brain activation and the specific areas modulated. This issue could
be addressed in a further study using another target system in the
brain in a control group.
FMRI-based neurofeedback is a holistic approach that over-
comes bio-psychological dualisms. It is therefore perfectly com-
patible with current models of depression and other complex
mental disorders. It can be used to help patients and researchers
understand the neural and cognitive processes that underlie
depression. Most importantly, however, if the clinical benefits are
replicated in clinical trials it may prove to be the first therapeutic
application of functional imaging in the field of mental health. We
can expect that knowledge about the contribution of dysfunctional
brain circuits to psychiatric symptoms will continue to accumulate,
which opens up the possibility of developing therapeutic imaging
protocols similar to the present one for a wide range of
neuropsychiatric disorders.
In this proof of concept study we demonstrate that patients with
depression can learn self-control of emotion-related brain areas
through fMRI-based neurofeedback. This procedure had clinical
benefits compared to a control group, which engaged in emotional
imagery outside the scanner, but further formal testing in
randomized trials with blinded assessments is needed in order to
assess the clinical efficacy.
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